Skip to main content

Table 2 Risk of breast cancer subgroups defined by clinico-pathological markers in relation to total duration of breastfeeding

From: Breastfeeding in relation to risk of different breast cancer characteristics

Tumour subgroup

Breastfeeding total in months

Number of cases

Incidence/100000

RR

RR*

Invasive

     

breast cancer**

<4.0

80

270

1.00

1.00

 

≥4.0 - <8.0

108

288

1.07 (0.80 - 1.42)

1.04 (0.77 - 1.40)

 

≥8.0 - <13.0

109

304

1.12 (0.84 - 1.49)

1.09 (0.80 - 1.48)

 

≥13.0

103

293

1.08 (0.81 - 1.45)

1.10 (0.78 - 1.54)

 

Missing

24

399

---

---

 

Total

424

294

p-trend: 0.56

p-trend:0.45

CIS

     
 

<4.0

9

30

1.00

1.00

 

≥4.0 - <8.0

19

51

1.67 (0.76 - 3.70)

1.90 (0.84 - 4.30)

 

≥8.0 - <13.0

13

36

1.20 (0.51 - 2.81)

1.40 (0.57 - 3.46)

 

≥13.0

13

37

1.22 (0.52 - 2.86)

1.59 (0.60 - 4.21)

 

Missing

3

50

---

---

 

Total

57

40

p-trend:0.98

p-trend:0.48

Size ≤20 mm#

     
 

<4.0

55

186

1. 00

1.00

 

≥4.0 - <8.0

80

214

1.15 (0.82 - 1.62)

1.12 (0.79 - 1.60)

 

≥8.0 - <13.0

69

192

1.03 (0.72 - 1.47)

0.99 (0.68 - 1.45)

 

≥13.0

85

241

1.30 (0.93 - 1.82)

1.29 (0.87 - 1.92)

 

Missing

15

249

---

---

 

Total

304

211

p-trend:0.21

p-trend:0.24

Size >20 mm

     
 

<4.0

25

84

1.00

1.00

 

≥4.0 - <8.0

27

72

0.85 (0.50 - 1.47)

0.84 (0.48 - 1.47)

 

≥8.0 - <13.0

39

109

1.28 (0.78 - 2.12)

1.28 (0.75 - 2.20)

 

≥13.0

18

51

0.61 (0.33 - 1.11)

0.65 (0.33 - 1.27)

 

Missing

9

150

---

---

 

Total

118

82

p-trend:0.36

p-trend:0.63

Axillary lymph

     

node neg#

<4.0

27

91

1.00

1.00

 

≥4.0 - <8.0

32

85

0.94 (0.56 - 1.56)

0.91 (0.54 - 1.54)

 

≥8.0 - <13.0

34

95

1.04 (0.63 - 1.72)

0.99 (0.56 - 1.70)

 

≥13.0

31

88

0.97 (0.58 - 1.62)

0.90 (0.50 - 1.64)

 

Missing

5

83

---

---

 

Total

129

89

p-trend:0.99

p-trend:0.82

Axillary lymph

     

node pos

<4.0

53

179

1.00

1.00

 

≥4.0 - <8.0

72

192

1.07 (0.75 - 1.53)

1.05 (0.73 - 1.51)

 

≥8.0 - <13.0

71

198

1.10 (0.77 - 1.57)

1.08 (0.73 - 1.57)

 

≥13.0

71

202

1.13 (0.79 - 1.61)

1.18 (0.78 - 1.79)

 

Missing

19

316

---

---

 

Total

286

198

p-trend: 0.52

p-trend:0.30

Grade I#

     
 

<4.0

27

91

1.00

1.00

 

≥4.0 - <8.0

37

99

1.08 (0.66 - 1.78)

1.01 (0.61 - 1.69)

 

≥8.0 - <13.0

28

78

0.85 (0.50 - 1.45)

0.78 (0.44 - 1.38)

 

≥13.0

28

80

0.87 (0.51 - 1.48)

0.87 (0.47 - 1.61)

 

Missing

7

116

---

---

 

Total

127

88

p-trend:0.42

p-trend:0.71

Grade II

     
 

<4.0

33

111

1.00

1.00

 

≥4.0 - <8.0

47

125

1.12 (0.72 - 1.75)

1.05 (0.67 - 1.66)

 

≥8.0 - <13.0

53

148

1.32 (0.85 - 2.03)

1.15 (0.73 - 1.83)

 

≥13.0

46

131

1.17 (0.75 - 1.83)

0.99 (0.60 - 1.64)

 

Missing

12

199

---

---

 

Total

191

132

p-trend:0.40

p-trend:0.97

Grade III##

     
 

<4.0

20

67

1.00

1.00

 

≥4.0 - <8.0

23

61

0.91 (0.45 - 1.66)

1.00 (0.54 - 1.85)

 

≥8.0 - <13.0

28

78

1.15 (0.65 - 2.05)

1.43 (0.77 - 2.66)

 

≥13.0

29

82

1.22 (0.69 - 2.16)

1.74 (0.89 - 3.41)

 

Missing

5

83

---

---

 

Total

105

73

p-trend:0.34

p-trend:0.051

  1. *Adjusted for age at baseline (continuous), education, socioeconomic status, marital status, age at menarche, age at first birth, parity, oophorectomy, age at menopause, oral contraceptive use, hormone replacement therapy use, bmi, alcohol consumption, smoking and height.
  2. **All cases with unilateral invasive breast cancer with tissue samples available for examination.
  3. #Reference group in heterogeneity analyses. ##Heterogeneity: p = 0.031.